The Ophthalmoplegia Market report summarizes the industry on the basis of treatment. The market is segmented into surgery, drug treatment, and others. The surgery sector is further segmented into strabismus surgery and others.
The Global Ophthalmoplegia Market report is segmented on the basis of end users, the market is segmented into hospital & clinics, ambulatory clinics, and others. Ophthalmoplegia Market Major Players: Abbott (US), Novartis AG (Switzerland), ZEISS International (Germany), Valeant Pharmaceuticals International, Inc.
(US), Amritt, Inc. (US), Medline Industries, Inc. (US), ALLERGAN (Ireland), and Johnson & Johnson (US).
Get Sample PDF Illustration @ www.marketresearchfuture.com/sample_request/4216 .
Ophthalmoplegia, also referred as extra ocular muscle palsy, is a paralysis of the extra ocular muscles that control movements of eyes. In this condition, nerve fibers that coordinate both eyes in horizontal movements looking from side to side- are damaged.
A number of devices and treatments are available in the market, which can cure or improve the eyesight of the patient. The Global ophthalmoplegia market is driven by increasing number of people with ophthalmoplegia and increasing geriatric population.
According to the World Health Organization in 2010, about 250 million people of over 50 years were suffering from visual impairment. Around 80% people in many of the developing countries have eye sight problems; of which nearly 50% of the people are not able to take treatment due to huge cost of the surgeries.
Increasing prevalence of eye sight affecting diseases, for instance, diabetes and rapid developments in technology have fuelled the growth of the market. On the other hand, high cost of the treatment and availability of cheap alternative treatment may slow the growth of the market.
The global ophthalmoplegia market is expected to grow at a CAGR of ~ 7.2 % during the forecast period 2017-2023.
Access report @ www.marketresearchfuture.com/check…mp;report_id=4216 .
Ophthalmoplegia Market Regional Analysis: The Americas dominates the global ophthalmoplegia market owing to well-developed technology and increased patient population with eye sight problem primarily due to increasing prevalence of diabetes. Additionally, high healthcare expenditure and the presence of some of the leading players have fuelled the growth of the market in this region.
Europe is the second largest ophthalmoplegia market, which is followed by Asia Pacific. Increasing government support and availability of funds for research drive the growth of the market.
Asia Pacific is the fastest growing ophthalmoplegia market due to increasing geriatric population and rapidly developing medical sector. On the other hand, the Middle East & Africa holds the least share of the market due to limited availability of medical facilities and poor economic and political conditions in Africa.
Major TOC for Ophthalmoplegia Market:
Market factor analysis
Global Ophthalmoplegia market, by type
Global Ophthalmoplegia Market, By Type of Content
Global Ophthalmoplegia market, by Treatments
Global Ophthalmoplegia market, by end user
Global Ophthalmoplegia market, by region
Access report @ www.marketresearchfuture.com/check-discount/4216 .
Ophthalmoplegia Market Information: By Types (External Opthalmoplegia, Internuclear Opthalmoplegia), By Treatment (Surgery, Drug Treatment), By End Users (Hospital & Clinics, Ambulatory Clinics) - Global Forecast Till 2023.
Category: Market Research Publishers and RetailersCompany about: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.